go777 log in

Ahmadu Bello Teaching Hospital to begin kidney transplant in 2025

A TikToker who went viral teaching science videos predicts short-form video will make its way into the national curriculum after 2024 saw him publish a new book and win a TikTok award. Emanuel Wallace, 27, from east London, is better known as Big Manny by his 1.9 million followers on TikTok, where he shares videos explaining various science experiments from his back garden while using Jamaican Patois phrases and London slang. In early December, Mr Wallace won the Education Creator of the Year award at the TikTok Awards ceremony, which he said is a “symbol that anything that you put your mind to you can achieve”. The content creator began making videos during the coronavirus pandemic when schools turned to online learning but has since expanded his teaching from videos to paper after releasing his debut book Science Is Lit in August. He believes his “unconventional” teaching methods help to make his content relatable for younger audiences by using slang deriving from his Jamaican and British heritage. “The language that I use, it’s a combination between Jamaican Patois and London slang because I have Jamaican heritage,” the TikToker, who holds a bachelors and masters degree in biomedical science, told the PA news agency. “That’s why in my videos sometimes I might say things like ‘Wagwan’ or ‘you dun know’. I just want to connect with the young people more, so I speak in the same way that they speak. “The words that I use, the way that I deliver the lesson as well, I would say that my method of teaching is quite unconventional. I speak in a way that is quite conversational.” Examples of his videos include lithium batteries catching fire after being sandwiched inside a raw chicken breast, as well as mixing gold with gallium to create blue gold, earning millions of views. Mr Wallace hopes his content will help make the science industry more diverse, saying “the scientists that I was taught about, none of them look like me”. “Now me being a scientist is showing young people that they can become one as well, regardless of the background that they come from, the upbringing that they’ve had,” he said. “I just want to make it seem more attainable and possible for them because if I can do it, and I come from the same place as you, there’s no reason why you can’t do it as well.” The TikToker has seen a shift in more young people turning to the app as a learning resource and feels short-form videos will soon become a part of the national curriculum in schools. “I’m seeing (young people) using that a lot more – social media as a resource for education – and I feel like in the future, it’s going to become more and more popular as well,” he said. “I get a lot of comments from students saying that my teacher showed my video in the classroom as a resource, so I feel like these short form videos are going to be integrated within the national curriculum at some point in the near future.” He also uses his platform to raise awareness of different social issues, which he said is “extremely important”. One of his videos highlighted an anti-knife campaign backed by actor Idris Elba, which earned more than 39 million views, while his clip about the banning of disposable vapes was viewed more than 4.6 million times. He said there is some pressure being a teacher with a large following online but hopes he can be a role model for young people. “I’m aware that I am in the public eye and there’s a lot of young people watching me,” he said. “Young people can be impressionable, so I make sure that I conduct myself appropriately, so that I can be a role model. “I always have the same message for young people, specifically. I tell them to stay curious. Always ask questions and look a little bit deeper into things.” His plans for 2025 include publishing a second Science Is Lit book and expanding his teaching to television where he soon hopes to create his own science show.Let's face it, nothing important happens in December. I'm scheduling 24 advent calendar posts this week and then spending the rest of the year eating boxes of Cadbury Mini Yule Logs Triple Chocolate. So it's no surprise that Devolver have announced their remaining slate of games aiming for release in 2024 are actually coming out in 2025. The games that slipped are Baby Steps , Skate Story , and Stick It To The Stickman. Devolver released the news with typical style, via the 15th annual Devolver Delayed awards, which you can watch below. I enjoyed the in memoriam section for games that released this year which can therefore no longer be delayed, all of which are currently available at a discount via Devolver's autumn sale on Steam . Baby Steps is the pick of the Delayed Three that I'm most looking forward to. It's a literal walking simulator from Bennett Foddy and the makers of Ape Out in which you pilot limbs individually to steer your pyjama-clad protagonist up a mountain, like a marriage between QWOP , Getting Over It , and whichever third-person game with a mountain you care to choose from. Skyrim? Jusant? I bet God Of War's got a mud-soaked hill in it somewhere. Skate Story is Tony Hawk's Pro Skater if Tony Hawk was a demon made out of glass. Stick It To The Stickman is that Flash animation you watched 20 years ago but with a physics simulation and made by the Broforce developers. I want to play both of these games, too. Check out the graphic design on these bad boys. The blurriness on the image of the mini roll isn't my camera, that's actually how it looks on the box.

Minnesota cannabis license lottery challenge moves to state appeals court

Best Bets for NCAA Basketball Picks Against the Spread for Friday, November 22Police in Ciudad Juarez, on the United States-Mexico border , have arrested two teenagers for allegedly holding four migrants captive and subjecting them to abuse for a month. The Mexican city's municipal police department said Tuesday that officers had been called to reports that the men were being held against their will. When the officers arrived at an address in La Campesina, they saw people waving, trying to get their attention. The department said the men, all from Jordan, had been subjected to abuse for 30 days by the 16- and 17-year-old suspects, who had frequently threatened to shoot them with a shotgun officers also found. The incident happened around 35 miles from the U.S. border crossing into El Paso, Texas, one of the busiest ports of entry along the southwest border . In Fiscal Year 2024, 7.7 million crossings were made there. Tuesday's incident is certainly not the first of its kind in Juarez, where many migrants arrive waiting for appointments with U.S. Customs and Border Protection. In June, the U.S. Department of Homeland Security worked with Mexican authorities to rescue 13 migrants who were being held against their will. The victims had been beaten, tortured, and sexually assaulted. Investigators were only able to locate the stash house—a property used by smugglers to house immigrants—because two other victims had escaped. They had entered the U.S. illegally, beaten and burned, and explained what had happened to them. In August, officials in Chihuahua announced they had rescued some 1,245 migrants from criminal gangs in the previous seven months. "We have diminished migration flows in terms of caravans and people arriving on trains. But I must point out we are seeing more people who are being kidnapped and extorted," Chihuahua State Public Safety Director Gilberto Loya said at the time. The International Rescue Committee (IRC) told Newsweek in July that migrants often turn to organized crime when they cannot reach the border alone. "Obviously, you're going to go to whoever lies to you and tells you that they will get you across the border for whatever amount of money they ask you," Rafael Velasquez Garcia, the IRC's director in Mexico, said. After Tuesday's rescue, Juarez police said the four Jordanians had been taken to the social work department at the University District police station, where they were given food and drink. The two suspects were charged with federal firearms and explosives charges, as well as the deprivation of liberty.

Jimmy Carter, the 39th president of the United States, has died at the age of 100. He died after spending more than a year in hospice care. Carter grew up on a peanut farm in Georgia and served in the U.S. Navy before turning to politics. He served one term as the president of the United States from 1977 to 1981. Following his time in the White House, Carter dedicated his life to humanitarian work, and was a major contributor to Habitat for Humanity. His post-presidential international diplomatic work earned him the Nobel Peace Prize in 2002. This report by The Canadian Press was first published Dec, 29, 2024.

Investors who purchased more than $100,000 in shares of DMC Global Inc. (NASDAQ: BOOM) between May and November 2024 have certain options and there are short and strict deadlines running. Deadline: February 04, 2025 . Those DMC Global Inc. (NASDAQ: BOOM investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. On October 21, 2024 , DMC Global Inc. disclosed that it was "revising its guidance" for the quarter ended September 30, 2024 , stating that the Company's adjusted EBITDA is now expected to be approximately $5 million , down from prior guidance for $15 -18 million, and that the third quarter financial results "will include inventory and bad debt charges at DynaEnergetics totaling approximately $5 million , as well as lower fixed overhead absorption on reduced sales at both Arcadia and DynaEnergetics." The Company also revealed that the financial results will include an approximate $142 million non-cash goodwill impairment charge "associated with DMC's December 2021 acquisition of a controlling interest in Arcadia ." On November 4, 2024 , DMC Global Inc released its third-quarter financial results for the period ending September 30, 2024 . Among other results, the Company reported third quarter sales of $152.4 million , down 11% sequentially and year-over-year, as well as the previously disclosed non-cash goodwill impairment charge. Shares of DMC Global Inc. (NASDAQ: BOOM) declined from $15.98 per share on May 3, 2024 , to as low as $7.16 per share on November 21 , 2024. On December 06, 2024 , an investor in NASDAQ: BOOM shares filed a lawsuit against DMC Global Inc. The plaintiff alleges that between May 3, 2024 and November 4, 2024 , the defendants made materially false and misleading statements and failed to disclose the following adverse facts about DMC Global's business, operations, and prospects which were known to defendants or recklessly disregarded by them: (i) the goodwill associated with the company's principal business segment, Acadia Products, was overstated due to the adverse events and circumstances affecting that reporting segment; (ii) DMC Global's materially inadequate internal systems and processes were adversely affecting its operations; (iii) the company's inadequate systems and processes prevented it from ensuring reasonably accurate guidance and that its public disclosures were timely, accurate, and complete; (iv) as a result, defendants misrepresented DMC Global's operations and financial results; and/or (v) as a result, the company's public statements were materially false, misleading, or lacked a reasonable basis when made. Those who purchased shares of DMC Global Inc. (NASDAQ: BOOM) should contact the Shareholders Foundation, Inc. CONTACT: Shareholders Foundation, Inc. Michael Daniels +1 (858) 779-1554 mail@shareholdersfoundation.com 3111 Camino Del Rio North Suite 423 San Diego, CA 92108 The Shareholders Foundation, Inc. is a professional portfolio legal monitoring and a settlement claim filing service, which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. The Shareholders Foundation, Inc. is not a law firm. Any referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is only provided as a public service. It is not intended as legal advice and should not be relied upon. View original content to download multimedia: https://www.prnewswire.com/news-releases/lawsuit-for-investors-who-lost-over-100-000-in-shares-of-dmc-global-inc-nasdaq-boom-between-may-and-nov-2024-announced-by-shareholders-foundation-302325435.html SOURCE Shareholders Foundation, Inc.Revealed: The bill to empty the Powerhouse Museum

Texas Instruments announces award agreement for CHIPS and Science Act funding

Ian Jackson scores career-high 26, UNC beats Campbell 97-81Michigan rolls to 112-64 victory over Western Kentucky

Secretary Buttigieg Urged to Embrace Domestic Green Shipbuilding

The standard Lorem Ipsum passage, used since the 1500s "Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum." Section 1.10.32 of "de Finibus Bonorum et Malorum", written by Cicero in 45 BC "Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque laudantium, totam rem aperiam, eaque ipsa quae ab illo inventore veritatis et quasi architecto beatae vitae dicta sunt explicabo. Nemo enim ipsam voluptatem quia voluptas sit aspernatur aut odit aut fugit, sed quia consequuntur magni dolores eos qui ratione voluptatem sequi nesciunt. Neque porro quisquam est, qui dolorem ipsum quia dolor sit amet, consectetur, adipisci velit, sed quia non numquam eius modi tempora incidunt ut labore et dolore magnam aliquam quaerat voluptatem. Ut enim ad minima veniam, quis nostrum exercitationem ullam corporis suscipit laboriosam, nisi ut aliquid ex ea commodi consequatur? Quis autem vel eum iure reprehenderit qui in ea voluptate velit esse quam nihil molestiae consequatur, vel illum qui dolorem eum fugiat quo voluptas nulla pariatur?" To keep reading, please log in to your account, create a free account, or simply fill out the form below.

Imran Khan, other PTI leaders face fresh charges after protest fiascoPresident El-Sisi Meets WEF PresidentNew York, USA, Dec. 20, 2024 (GLOBE NEWSWIRE) -- Stay Ahead in Ophthalmology: Strategic Market Insights for Myopia Assessment & Forecasting | DelveInsight A case study on how a leading company turned to DelveInsight for long-term market assessment and forecast support in the myopia market. DelveInsight provided accurate data on the target myopia patient population, enabling the client to effectively tailor their strategies and interventions to address specific needs and demographics, ensuring a competitive edge in the domain. DelveInsight, a leader in healthcare competitive intelligence and consulting company, released a success study on Competitive Intelligence in the Myopia Market . A client approached DelveInsight to conduct an epidemiological study of myopia in children across Asian markets. The client sought to understand the prevalence and severity of myopia in children, including age-specific incidence rates and severity levels, to identify the target patient population accurately. Myopia, commonly known as nearsightedness, is a refractive error of the eye where distant objects appear blurry while close objects can be seen clearly. In 2023 , the prevalent cases in the US were 2.5 million , as per DelveInsight’s assessment in the latest published Myopia Epidem and Market Forecast Report . A study conducted in Japan highlighted alarming rates of myopia among schoolchildren, with 76.5% of elementary school students and 94.9% of junior high school students affected. Furthermore, high myopia prevalence was recorded at 4% in elementary school students and 11.3% in junior high school students. These trends emphasize the growing patient burden, underscoring the need for effective prevention and management strategies to address the escalating myopia epidemic. Approved products for myopia treatment include MiSight® 1-Day Soft Contact Lenses , ACUVUE® AbilitiTM Overnight Therapeutic Lenses , SightGlass Vision's Diffusion Optics Technology (DOT) Spectacle Lenses , and Byooviz (ranibizumab-nuna) . The clinical trial pipeline for myopia treatments is highly promising, with several mid-to-late-stage advancements underway. Notable examples include EssilorLuxottica's Stellest lenses , Cloudbreak Pharma's CBT-009 , Sydnexis' SYD-101 , and Kubota's wearable device for myopia control . These innovations hold significant potential to reshape the market and revolutionize myopia management, offering renewed hope for effective treatment solutions in the field. Leading companies such as Essilor Group, Sydnexis , Sunhawk Vision Biotech, Vyluma, Eyenovia, Cloudbreak Therapeutics, Stuart Therapeutics, and others are at the forefront of advancing myopia treatments. Ongoing research offers renewed hope for better management and potential breakthroughs in the field. DelveInsight provided a comprehensive analysis, enabling the client to gain strategic insights into the competitive landscape and market dynamics. By understanding these factors, the client made informed decisions regarding market entry, differentiation, and resource allocation, potentially leading to increased market share and revenue growth in the myopia space. Let's discuss the problem statement the client faced and how DelveInsight's methodology provided a tailored solution. By leveraging a structured approach, DelveInsight addressed the client's challenges effectively, offering actionable insights to navigate the myopia market successfully. Problem Statement of the Client in the Myopia Market Our client engaged us to conduct a detailed study of myopia in children across the APAC region, with the following objectives: Analyze current and emerging treatment patterns for myopia. Assess prevalence and distribution by gender (male and female). Understand age-wise segmentation of myopia prevalence. Analyze and forecast the patient population by country. Categorize the population based on the severity of myopia. Gather insights from Key Opinion Leaders (KOLs) on prescribed treatments. Examine factors influencing treatment decisions and outcomes. Determine the current and future market size for myopia treatments. Identify dynamic shifts in treatment paradigms over time. Forecast treatment uptake and market share of therapies through the forecast period (up to 2032). Market share comparisons between treatment-based approaches and symptomatic management within each country-specific market. Outcome of DelveInsight’s Myopia Market Assessment & Forecast DelveInsight's epidemiological study offered comprehensive data on the prevalence and severity of myopia in children across key countries, including China and South Korea,, including specific age-related incidence and severity rates. DelveInsight's market assessments in leading APAC countries provided a deep understanding of the myopia treatment landscape, revealing competitive dynamics and identifying potential opportunities for market entry. By focusing on the moderate-to-severe myopia population, our research provided strategic insights to optimize the client's approach to market entry and address the most impactful patient group. We recommended a unique product positioning strategy that emphasized the client's treatment-based approach, distinguishing it from a market primarily focused on managing symptoms. KOL insights helped refine the treatment approach, providing valuable input on emerging trends and unmet clinical needs in myopia care. Market forecasts provided critical data on future growth potential, allowing the client to align its strategy with projected market trends and ensure sustainable market success. Why Choose DelveInsight? DelveInsight offers comprehensive capabilities in the ophthalmology domain, providing in-depth market research, consulting services, and pipeline analysis tailored to the evolving needs of the industry. With a keen focus on ocular diseases, DelveInsight delivers robust reports covering emerging therapies, market trends, competitive landscapes, and unmet needs. DelveInsight's ophthalmology-specific solutions empower stakeholders to make data-driven decisions, optimize their R&D efforts, and capitalize on growth opportunities in the dynamic and innovative ophthalmology market. Competitive Intelligence Services : DelveInsight’s competitive intelligence services provide real-time, accurate insights across the pharmaceutical, life sciences, and medical diagnostics sectors, helping clients stay ahead in a dynamic market. With over 100 years of combined experience, our experts deliver actionable strategic insights backed by robust research methodologies to support critical business decisions and create a competitive advantage for our clients. About DelveInsight DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports pharma companies by providing comprehensive end-to-end solutions to improve their performance. Get hassle-free access to all the healthcare and pharma market research reports through our subscription-based platform PharmDelve .

Cyber cheats dupe citizens of ₹1.58 croreRucker's 27 lead Army past UTSA 78-75